369
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Infection Prevalence at a Tertiary Hospital in Hail, Saudi Arabia: A Single-Center Study to Identify Strategies to Improve Antibiotic Usage

, , , , , , , , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 3719-3728 | Received 11 Apr 2023, Accepted 02 Jun 2023, Published online: 13 Jun 2023

References

  • Alghamdi A, Alamoudi O, Ghabrah T, Al-Kassimi M. Pattern of infectious diseases in the western region of Saudi Arabia; a study of 495 hospitalized patients. J King Abdulaziz Univ Med Sci. 2009;16(2):3–15. doi:10.4197/Med.16-2.1
  • Blas E, Sommerfeld J. Editorial. Int J Health Plann Manage. 2004;19(S1):S1–S2. doi:10.1002/HPM.780
  • Straif-Bourgeois S, Ratard R, Kretzschmar M. Infectious Disease Epidemiology. Handbook Epidemiol. 2014;2041. doi:10.1007/978-0-387-09834-0_34
  • Mounts AW, Holman RC, Clarke MJ, Bresee JS, Glass RI. Trends in hospitalizations associated with gastroenteritis among adults in the United States, 1979-1995. Epidemiol Infect. 1999;123(1):1–8. doi:10.1017/s0950268899002587
  • Wendel AF, Malecki M, Mattner F, et al. Genomic-based transmission analysis of carbapenem-resistant pseudomonas aeruginosa at a tertiary care centre in cologne (Germany) from 2015 to 2020. JAC Antimicrob Resist. 2022;4(3). doi:10.1093/JACAMR/DLAC057
  • Kueakulpattana N, Wannigama DL, Luk-in S, et al. Multidrug-Resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Sci Rep. 2021;11(1). doi:10.1038/S41598-021-00675-Y
  • Shein AMS, Wannigama DL, Higgins PG, et al. Novel Colistin-EDTA Combination for Successful Eradication of Colistin-Resistant Klebsiella Pneumoniae Catheter-Related Biofilm Infections. Sci Rep. 2021;11(1). doi:10.1038/S41598-021-01052-5
  • Izadi S, Mohaghegh MA, Ghayour-Najafabadi Z, et al. Frequency and molecular identification of cryptosporidium species among immunocompromised patients referred to hospitals, central Iran, 2015-2016. Int J Med. 2015;15(1):31–39.
  • Srisakul S, Wannigama DL, Higgins PG, et al. Overcoming addition of phosphoethanolamine to lipid a mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy. Sci Rep. 2022;12(1). doi:10.1038/S41598-022-15386-1
  • Tacconelli E, Göpel S, Gladstone BP, et al. Development and Validation of BLOOMY Prediction Scores for 14-Day and 6-Month Mortality in Hospitalised Adults with Bloodstream Infections: a Multicentre, Prospective, Cohort Study. Lancet Infect Dis. 2022;22(5):731–741. doi:10.1016/S1473-3099(21)00587-9
  • Camargo CH, Yamada AY, Nagamori FO, et al. Clonal Spread of ArmA- and OXA-23-Coproducing Acinetobacter Baumannii International Clone 2 in Brazil during the First Wave of the COVID-19 Pandemic. J Med Microbiol. 2022;71(4). doi:10.1099/JMM.0.001509
  • Nicoloff H. Standing up to Infectious Disease. Nat Microbiol. 2019;4(1):41564. doi:10.1038/s41564-018-0331-3
  • Ellwanger JH, Kaminski V, Chies JAB. Emerging infectious disease prevention: where should we invest our resources and efforts? J Infect Public Health. 2019;12(3):313–316. doi:10.1016/j.jiph.2019.03.010
  • Albanghali M, Alghamdi S, Alzahrani M, et al. Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: a Single Centre Study. J Infect Public Health. 2022;15(3):331–337. doi:10.1016/J.JIPH.2022.02.001
  • Alzahrani M, Ali M, Anwar S. Bacteria Causing Urinary Tract Infections and Its Antibiotic Susceptibility Pattern at Tertiary Hospital in Al-Baha Region, Saudi Arabia: a Retrospective Study. J Pharm Bioallied Sci. 2020;12(4):449. doi:10.4103/JPBS.JPBS_294_19
  • Alzahrani MA, Sadoma HHM, Mathew S, Alghamdi S, Malik JA, Anwar S. Retrospective analysis of antimicrobial susceptibility of uropathogens isolated from pediatric patients in tertiary hospital at Al-Baha Region, Saudi Arabia. Healthcare. 2021;9(11):1564. doi:10.3390/HEALTHCARE9111564
  • Tyrovolas S, El Bcheraoui C, Alghnam SA, et al. The Burden of Disease in Saudi Arabia 1990–2017: results from the Global Burden of Disease Study 2017. Lancet Planet Health. 2020;4(5):e195–e208. doi:10.1016/S2542-5196(20)30075-9
  • Murray CJ, Ikuta KS, Sharara F, et al. Global Burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0/ATTACHMENT/B227DEB3-FF04-497F-82AC-637D8AB7F679/MMC1.PDF
  • Tabish SA. Recent Trends in Emerging Infectious Diseases. Int J Health Sci. 2009;3(2):V–VIII.
  • Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health. 2022;15(2):228–240. doi:10.1016/J.JIPH.2021.12.014
  • Ahmad Malik J, Ahmed S, Shinde M, et al. The impact of COVID-19 on comorbidities: a review of recent updates for combating it. Saudi J Biol Sci. 2022;29(5):3586–3599. doi:10.1016/J.SJBS.2022.02.006
  • Farooqi T, Malik JA, Mulla AH, et al. An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies. J Infect Public Health. 2021;14(10):1299–1312. doi:10.1016/J.JIPH.2021.08.014
  • Malik JA, Mulla AH, Farooqi T, Pottoo FH, Anwar S, Rengasamy KRR. Targets and strategies for vaccine development against SARS-CoV-2. Biomed Pharmacother. 2021;137:111254. doi:10.1016/J.BIOPHA.2021.111254
  • Malik JA, Aroosa M, Ahmed S, et al. SARS-CoV-2 vaccines: clinical endpoints and psychological perspectives: a literature review. J Infect Public Health. 2022;15(5):515–525. doi:10.1016/J.JIPH.2022.03.017
  • McGowan JE. Economic impact of antimicrobial resistance. Emerg Infect Dis. 2001;7(2):286–292. doi:10.3201/EID0702.010228
  • Shibl AM, Memish ZA, Kambal AM, et al. National surveillance of antimicrobial resistance among gram-positive bacteria in Saudi Arabia. J Chemother. 2014;26(1):13–18. doi:10.1179/1973947813Y.0000000084
  • Zowawi HM. Antimicrobial Resistance in Saudi Arabia. An Urgent Call for an Immediate Action. Saudi Med J. 2016;37(9):935–940. doi:10.15537/SMJ.2016.9.16139
  • Wanla W, Katip W, Supakul S, Apiwatnakorn P, Khamsarn S. Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation. Taylor & Francis. 2017;10:443–449. doi:10.2147/IJGM.S145133
  • Balkhy HH, Cunningham G, Chew FK, et al. Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis. 2006;10(4):326–333. doi:10.1016/J.IJID.2005.06.013
  • Safdar OY, Alzahrani WA, Kurdi MA, et al. The Prevalence of Renal Stones among Local Residents in Saudi Arabia. J Family Med Prim Care. 2021;10(2):974. doi:10.4103/JFMPC.JFMPC_262_20
  • Alzahrani MA, Sadoma HHM, Mathew S, Alghamdi S, Malik JA, Anwar S. Retrospective analysis of antimicrobial susceptibility of uropathogens isolated from pediatric patients in tertiary hospital at al-baha region, Saudi Arabia. Healthcare. 2021;9(11):1–11. doi:10.3390/healthcare9111564
  • Alshamrani MM, El-Saed A, Alsaedi A, et al. Burden of healthcare-associated infections at six tertiary-care hospitals in Saudi Arabia: a point prevalence survey. Infect Control Hosp Epidemiol. 2019;40(3):355–357. doi:10.1017/ice.2018.338
  • Merga Duffa Y, Terfa Kitila K, Mamuye Gebretsadik D, Bitew A. Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia. Int J Microbiol. 2018;2018. doi:10.1155/2018/8492309
  • Alzahrani MA, Ali MS, Anwar S. Bacteria causing urinary tract infections and its antibiotic susceptibility pattern at tertiary hospital in al-baha region, Saudi Arabia: a retrospective study. J Pharm Bioallied Sci. 2020;12(4):449. doi:10.4103/JPBS.JPBS_294_19
  • Ferrara P, Cutrona C, Sbordone A. Which treatment for upper respiratory tract infections? Ital J Pediatr. 2015;41(Suppl 2):A31. doi:10.1186/1824-7288-41-S2-A31
  • Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138–1180. doi:10.1183/09031936.05.00055705
  • Yoon YK, Park C-S, Kim JW, et al. Guidelines for the antibiotic use in adults with acute upper respiratory tract infections. Infect Chemother. 2017;49(4):326. doi:10.3947/IC.2017.49.4.326
  • Ieven M, Coenen S, Loens K, et al. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clin Microbiol Infect. 2018;24(11):1158–1163. doi:10.1016/J.CMI.2018.02.004
  • Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25(3):584–599. doi:10.1086/513766
  • Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013;10(9):4274. doi:10.3390/IJERPH10094274